Literature DB >> 22042787

Second malignancies among elderly survivors of cancer.

Ari M VanderWalde1, Arti Hurria.   

Abstract

The U.S. population is aging, life expectancy is increasing, and cancer is a disease associated with aging. Advances in screening and therapeutics have led to a growing number of cancer survivors who are at risk for the development of secondary malignancies. Although the risks for the development of second malignancies following a first diagnosis of cancer are well described for survivors of childhood malignancies, there are fewer data for malignancies common in older adults. With the aging of the U.S. population, and with improving survival statistics in many adult malignancies, there is an increasing need to identify those second malignancies that might develop in the older adult survivor of cancer. In this paper, we describe the types and rates of second malignancies following cancers commonly seen in older adults and review the literature on these malignancies. Comparisons are made between older and younger adults with regard to the risks for developing treatment-related cancers with different modalities. Recommendations for early detection of second malignancies are summarized, though there remains an unmet need for evidence-based guidelines for screening for second malignancies in the older adult in particular.

Entities:  

Mesh:

Year:  2011        PMID: 22042787      PMCID: PMC3233292          DOI: 10.1634/theoncologist.2011-0214

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  63 in total

1.  Second primary cancers after cancers of the colon and rectum in New South Wales, Australia, 1972-1991.

Authors:  M McCredie; G J Macfarlane; J Bell; M Coates
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-03       Impact factor: 4.254

Review 2.  Mechanisms of therapy-related carcinogenesis.

Authors:  James M Allan; Lois B Travis
Journal:  Nat Rev Cancer       Date:  2005-12       Impact factor: 60.716

3.  Hodgkin's disease: complications of therapy and excess mortality.

Authors:  R T Hoppe
Journal:  Ann Oncol       Date:  1997       Impact factor: 32.976

Review 4.  Genetic predisposition to ocular melanoma.

Authors:  R S Houlston; B E Damato
Journal:  Eye (Lond)       Date:  1999       Impact factor: 3.775

5.  Risk for colorectal cancer after gynecologic cancer.

Authors:  D S Weinberg; C J Newschaffer; A Topham
Journal:  Ann Intern Med       Date:  1999-08-03       Impact factor: 25.391

6.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

7.  Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma.

Authors:  A I Neugut; H Ahsan; E Robinson; R D Ennis
Journal:  Cancer       Date:  1997-04-15       Impact factor: 6.860

8.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

Authors:  B Fisher; J P Costantino; D L Wickerham; C K Redmond; M Kavanah; W M Cronin; V Vogel; A Robidoux; N Dimitrov; J Atkins; M Daly; S Wieand; E Tan-Chiu; L Ford; N Wolmark
Journal:  J Natl Cancer Inst       Date:  1998-09-16       Impact factor: 13.506

9.  Risk of leukemia after platinum-based chemotherapy for ovarian cancer.

Authors:  L B Travis; E J Holowaty; K Bergfeldt; C F Lynch; B A Kohler; T Wiklund; R E Curtis; P Hall; M Andersson; E Pukkala; J Sturgeon; M Stovall
Journal:  N Engl J Med       Date:  1999-02-04       Impact factor: 91.245

10.  Second malignant neoplasms among long-term survivors of ovarian cancer.

Authors:  L B Travis; R E Curtis; J D Boice; C E Platz; B F Hankey; J F Fraumeni
Journal:  Cancer Res       Date:  1996-04-01       Impact factor: 12.701

View more
  10 in total

1.  Multiple cancers of the head and neck.

Authors:  Adriana-Daniela Heroiu Cataloiu; Cezara Elisabeta Danciu; Cristian Radu Popescu
Journal:  Maedica (Bucur)       Date:  2013-03

2.  Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual.

Authors:  Andrew L Laccetti; Sandi L Pruitt; Lei Xuan; Ethan A Halm; David E Gerber
Journal:  J Natl Cancer Inst       Date:  2015-02-09       Impact factor: 13.506

3.  Modified metabolic syndrome and second cancers in women: A case control study.

Authors:  Carlos-Manuel Ortiz-Mendoza; Ernesto Pérez-Chávez; Tania-Angélica De-la Fuente-Vera
Journal:  South Asian J Cancer       Date:  2016 Oct-Dec

4.  Advanced Tracheal Adenoid Cystic Carcinoma with Thyroid Invasion Mimicking Thyroid Cancer Treated with Definitive Radiation: Case Report and Review of the Literature.

Authors:  Sondos Al Khatib; Wafa Asha; Omar Khzouz; Farid Barakat; Jamal Khader
Journal:  Case Rep Oncol       Date:  2017-08-04

5.  Multiple primary malignancies: synchronous urothelial carcinoma of the bladder and adenocarcinoma of the colon.

Authors:  Rodolfo Mendes Queiroz; Daniel Roque; Eduardo Miguel Febronio
Journal:  Radiol Bras       Date:  2017 Jan-Feb

6.  Incidence of adrenal gland tumor as a second primary malignancy: SEER-based study.

Authors:  Wafaa M Rashed; Anas M Saad; Muneer J Al-Husseini; Ahmed Mahmoud Galal; Assem Mohamed Ismael; Ahmed M Al-Tayep; Ayman El Shafie; Mahmoud Ahmed Ali; Ahmed Samir Alfaar
Journal:  Endocr Connect       Date:  2018-08-23       Impact factor: 3.335

7.  Mortality of lung cancer as a second primary malignancy: A population-based cohort study.

Authors:  Lei Deng; Hrönn Harðardottír; Huan Song; Zhengrui Xiao; Changchuan Jiang; Qian Wang; Unnur Valdimarsdóttir; Haiying Cheng; Billy W Loo; Donghao Lu
Journal:  Cancer Med       Date:  2019-04-16       Impact factor: 4.452

8.  Long-term survival among patients with gastrointestinal stromal tumors diagnosed after another malignancy: a SEER population-based study.

Authors:  Chaoyong Shen; Chengshi Wang; Tao He; Zhaolun Cai; Xiaonan Yin; Yuan Yin; Donghao Lu; Bo Zhang; Zongguang Zhou
Journal:  World J Surg Oncol       Date:  2020-05-06       Impact factor: 2.754

9.  Second primary malignancy risk after radiotherapy in rectal cancer survivors.

Authors:  Ti-Hao Wang; Chia-Jen Liu; Tze-Fan Chao; Tzeng-Ji Chen; Yu-Wen Hu
Journal:  World J Gastroenterol       Date:  2018-10-28       Impact factor: 5.742

10.  The effect of prior cancer on non-small cell lung cancer trial eligibility.

Authors:  Michael Herman; Zhihui Liu; Frances A Shepherd; Natasha Leighl; Geoffrey Liu; Penelope A Bradbury
Journal:  Cancer Med       Date:  2021-06-18       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.